- Home
- TORO vs RFL Comparison
TORO vs RFL Comparison
Compare TORO & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TORO
- RFL
- Stock Information
- Founded
- TORO 2022
- RFL 2017
- Country
- TORO Cyprus
- RFL United States
- Employees
- TORO N/A
- RFL N/A
- Industry
- TORO Marine Transportation
- RFL Real Estate
- Sector
- TORO Consumer Discretionary
- RFL Finance
- Exchange
- TORO Nasdaq
- RFL Nasdaq
- Market Cap
- TORO 55.1M
- RFL 51.1M
- IPO Year
- TORO N/A
- RFL N/A
- Fundamental
- Price
- TORO $2.54
- RFL $1.89
- Analyst Decision
- TORO
- RFL
- Analyst Count
- TORO 0
- RFL 0
- Target Price
- TORO N/A
- RFL N/A
- AVG Volume (30 Days)
- TORO 22.9K
- RFL 29.1K
- Earning Date
- TORO 03-18-2025
- RFL 03-17-2025
- Dividend Yield
- TORO N/A
- RFL N/A
- EPS Growth
- TORO N/A
- RFL N/A
- EPS
- TORO 0.99
- RFL N/A
- Revenue
- TORO $80,626,531.00
- RFL $697,000.00
- Revenue This Year
- TORO N/A
- RFL N/A
- Revenue Next Year
- TORO N/A
- RFL N/A
- P/E Ratio
- TORO $0.90
- RFL N/A
- Revenue Growth
- TORO 52.03
- RFL 151.62
- 52 Week Low
- TORO $2.25
- RFL $1.29
- 52 Week High
- TORO $6.06
- RFL $2.50
- Technical
- Relative Strength Index (RSI)
- TORO 36.37
- RFL 42.09
- Support Level
- TORO $2.46
- RFL $1.81
- Resistance Level
- TORO $2.62
- RFL $2.02
- Average True Range (ATR)
- TORO 0.10
- RFL 0.11
- MACD
- TORO -0.01
- RFL -0.02
- Stochastic Oscillator
- TORO 27.59
- RFL 30.88
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.